NEW YORK (360Dx) — Irish diagnostics firm Trinity Biotech reported today revenues of $24.6 million for the fourth quarter of 2018, essentially unchanged from the same period a year earlier amid a drop in revenues from its clinical laboratory operations.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.